University of Cape Town (UCT)
Universiteit van Kaapstad

South Africa

Umthombo

The University of Cape Town’s geographical vantage point at the tip of Africa offers an exhilarating research environment that combines excellence with impact.

As a leading research university (1st in Africa THE, QS, 2017-18; 171 in the world THE 2017-18), UCT is one of the best places in the world to research Africa-specific problems, from the chemistry of malarial drug discovery to the development of urban Africa. We have strong collaborative networks across the globe, and often form a nexus of partnerships between researchers in the global north and global south, particularly Africa. UCT is the first university in Africa to join the International Alliance of Research Universities (IARU). It is therefore not surprising that we attract researchers — from postgraduates and postdoctoral fellows to leaders in their field — from all over the continent and the world.

Experts in the southern skies

UCT is fast becoming Africa’s astronomy and cosmology hub. It includes global leaders in their field, such as Professor George Ellis, who co-wrote The Large Scale Structure of Space-Time with Stephen Hawking; Professor Michael Feast, who published his first paper in Nature at 21 and his most recent at the age of 87; and Professor Russ Taylor, who is leading our involvement in the Square Kilometre Array (SKA) project and the big data challenges it brings.

Climate and development

UCT has extensive interdisciplinary expertise in conservation, climate adaptation and community conflict. The AXA Research Fund awarded its first research chair in Africa to the director of the African Climate & Development Initiative, a leading interdisciplinary research group. The Percy FitzPatrick Institute was identified as a Centre of Excellence (CoE) in Birds as Keys to Biodiversity Conservation in 2004; UCT ranks 3rd in the world in ornithology (CWUR 2017). The Future Water Institute builds on UCT’s substantial research footprint in water and encompasses the skills and resources of 10 different departments across six faculties.

Healthcare for Africa

In a country that faces four epidemics, where most countries only have one or two, UCT has developed unique expertise in addressing healthcare in Africa. The Institute of Infectious Disease and Molecular Medicine (IDM) and the Drug Discovery and Development Centre (H3D) have produced ground-breaking research, particularly in HIV, TB and malaria. A Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) – the first of its kind in Africa – will be established at UCT. In 2017, UCT received the highest number of direct awards, as well as the highest amount of funding, from the US National Institutes of Health (NIH) of any other higher education institution outside the US.

Read the latest issue of Umthombo, our magazine featuring research stories from across the university. Umthombo is the isiXhosa word for a natural spring of water or fountain. The most notable features of a fountain are its natural occurrence and limitlessness. Umthombo as a name positions the University of Cape Town, and this publication in particular, as an undepletable well of knowledge. In the context of the Cape Town water crisis, Umthombo represents hope itself.

1 August 2017 - 31 July 2018

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for University of Cape Town (UCT) published between 1 August 2017 - 31 July 2018 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

AC	FC
143	11.41

Outputs by subject (FC)

Subject	AC	FC
Physical Sciences	86	2.54
Life Sciences	38	4.01
Earth & Environmental Sciences	16	4.17
Chemistry	3	0.84

Highlight of the month

Inflammation undermines HIV prevention

© Science Photo Library - MEHAU KULYK/Getty

Genital inflammation interferes with the effectiveness of a topical gel to prevent HIV acquisition.

A South African-led team, including researchers from the University of Cape Town, measured levels of nine inflammatory molecules in vaginal tract cells collected from sexually active young women who participated in a randomized, placebo-controlled clinical trial of a microbicidal gel designed to prevent HIV infection.

They found that the prophylactic gel worked well among women without genital inflammation: the therapy reduced HIV infections by 75 per cent relative to the placebo when applied as directed for most sexual interactions. There was no such protection, however, among women with elevated inflammatory markers in the vaginal environment, even with proper usage of the gel.

The findings suggest that reducing genital inflammation could enhance the ability of antiretroviral gels to thwart HIV transmission during sex in at-risk populations.

Supported content